肝炎病毒

Download Report

Transcript 肝炎病毒

HEPATITIS VIRUSES
肝炎病毒
HAV甲型肝炎病毒
HBV乙型肝炎病毒
HCV丙型肝炎病毒
HDV丁型肝炎病毒
HEV戊型肝炎病毒
HFV 已型肝炎病毒
HGV 庚型肝炎病毒
TTV TT型肝炎病毒
Hepatitis A virus,HAV
甲型肝炎病毒
Biological Properties
 picornavirus, +ssRNA
genome小RNA病毒科

27 nm in diameter ,nonenveloped icosahedral particle
27nm, 球形, 20面立体对称,
无包膜

one serotype一个血清型
Feinstone
(1973)

Stronger than enterovirus, resistant to detergents,
acid (pH 1.0 for 2h), 60℃ for 1h,survive for
months in fresh water and salt water
抵抗力比肠道病毒强
Pathogenesis致病性
spread via the fecal-oral route粪-口途径传播
 Source of infection: patient, inapparent infection
传染源: 病人、隐性感染者
 Viral shedding in the stool precedes the onset of
symptoms by 14d but stops before the cessation of
symptoms
 Symptoms

– Initial symptoms: fever, fatigue, nausea, loss of appetite,
abdominal pain
– Jaundice
HAV的致病性
粪-口途径传播
小肠淋巴结中大量增殖
入血并形
成病毒血
症
通过胆汁随粪
便排出体外
肝脏为最终靶
器官(病毒直
接损伤或免疫
病理作用)

Asymptomatic infections are very common. As already
noted, disease in children is generally milder than that in
adults and is usually asymptomatic隐性感染多

No a chronic infection and carrier,not associated with
hepatic cancer.无慢性病例和病毒携带者,不与肝癌有关

Complete recovery:99% 预后好

Fulminant hepatitis暴发性肝炎: 1~3 / 1000, 80%
mortality rate死亡率

Pregnant women may develop more severe disease.
孕妇感染严重
Mechanisim of pathogenisis致病机理:

Directly injury by virus病毒直接损伤

immunopathogenesis免疫病理作用
immunity免疫性
无论显性感染还是隐性感染
均能产生抗-HAV的 IgM和IgG抗体
抗-HAV的IgM在急性期和恢复早期出现
阳性可作为甲肝的确诊依据
抗-HAV的IgG在恢复后期出现
有保护作用,维持终身
Laboratory Diagnosis微生物学检查
anti-HAV IgM 抗-HAV IgM
 by an ELISA or radioimmunoassay

Treatment and Prevention
防治原则

Control the source of infection控制传染源

Cut down the route of transmission切断传播途径

Passive immunization - Normal immunoglobulin
丙种球蛋白
 Active immunizations
– A killed HAV vaccine
– a live attenuated HAV vaccine
hepatitis B virus, HBV乙型肝炎病毒
SHAPE AND STRUCTURE
形态结构
There are 3 particles in patient’s blood

Dane particle Dane颗粒(大球形颗粒)
 small spherical particle小球形颗粒
 tubulose particle管形颗粒
Dane particle
Complete particle, infective HBV
spherical,double capsid球形,双层衣壳。
outer capsid=envelope
外衣壳=包膜(脂质双层+蛋白质)
HBsAg等
inner capsid内衣壳: HBcAg、HBeAg
internal内部:
DNA--- circular, double- stranded环状双链
DNA polymerase 多聚酶
HBV的小球形颗粒
HBsAg-containing particles
过剩的衣壳蛋白装配而成
HBV的管形颗粒
小球形颗粒串联而成
Genome of HBV
•a circular, double-stranded DNA
containing single-strand breaks 不完
全双链环状DNA
four open reading frames that
encode seven polypeptides. 含4个
ORF,编码7个蛋白
•S
HBsAg,Pre-s1,Pre-s2
•C
HBcAg,HBeAg
•P
polymerase多聚酶
•X
HBxAg基因
Antigen of HBV抗原组成
Antigen of outer capsid外衣壳抗原

hepatitis B surface antigenHBsAg表面抗原
– indicates that virus replication is occurring in
the liver
说明病毒在肝中复制(机体受感染标志)
– four phenotypes:adr,adw,ayr,ayw
– anti-HBs:neutralization
antibody中和抗体
Antigens
of inner capsid内衣壳抗原

hepatitis B core antigen HBcAg核心抗原
– not found in blood一般不能检出
– anti-HBc non-neutralization antibody非中和抗体
– Core IgM indicates recent infection. 抗-HBc IgM
说明HBV复制
– Core IgG indicates exposure to HBV

hepatitis B e antigen e抗原HBeAg
–the best correlate to the presence of
infectious virus. 感染性病毒存在的最有效证据
(复制及具传染性的标志)
–anti-HBe indicates low infectivity in a
carrier
抗HBe说明病毒感染性较低(是预后良好的征象)


culture培养
resistance抵抗力
strong
resistance to cool,dry, ultraviolet, alcohol
inactivate: 100℃ 10min
Pathogenesis and Immunity

source of infection传染源
patients or carriers
急性、慢性患者或无症状HBsAg携带者
 route of transmission传播途径
– sexual routes
– parenteral肠胃外的 routes


injection of the virus into the blood stream
contaminated blood and blood components by transfusion,
needle sharing, acupuncture针灸, ear piercing, or tattooing
– perinatal围产期 routes

contact with the mother’s blood at birth and in mother’ milk
Pathogenesis of HBV致病性
Cell-mediated immunity (liver injury)
 Immune complexes ( HBsAg + anti-HBs) :
development of hypersensitivity reactions
(other organs injury)
infants infected perinatally become
chronic carriers

Clinical Findings

Acute infection急性感染
 Fulminant hepatitis暴发型肝炎
 Chronic infection 慢性感染
 Primary hepatocellular carcinoma
(PHC)原发性肝细胞癌
Acute infection

a long incubation period and an insidious onset
 prodromal period前驱期 :fever, malaise不适,
anorexia食欲缺乏, nausea, vomiting, abdominal
discomfort, chills
 classic icteric黄疸 symptoms of liver damage
 Recovery
Fulminant hepatitis
暴发型肝炎

occurs in approximately 1% of icteric
patients and may be fatal
1% 黄疸病人,可致死
 severe liver damage, such as ascites and
bleeding
肝严重受损,腹水,出血
Chronic infection
elevated liver enzyme levels 转氨酶水平高
 10% of patients with chronic hepatitis may
develop cirrhosis and liver failure
10% 可发展为肝硬化和肝衰竭
 major source for spread of the virus主要传
染源
 at risk for fulminant disease if they become
co-infected with HDV

Primary hepatocellular carcinoma
(PHC)
原发性肝细胞癌

promoting continued liver repair and cell
growth in response to tissue damage
 integrating into the host chromosome and
stimulating cell growth directly
Laboratory Diagnosis
乙肝“两对半”及临床意义
抗HBs
 HBeAg、 抗HBe
 (HBcAg) 抗HBc
 HBsAg、
HBV抗原抗体系统检测临床意义
HBsAg
HBeAg 抗-HBe
抗-HBc
抗-HBs
临床意义
IgM IgG
+
-
-
-
-
-
感染或无症状携带者
+
+
-
+
-
-
+
+
-
-
+
-
+
-
+
-
-
+
-
+
+
急性乙型肝炎(有传染)
(大三阳)
慢性乙型肝炎(有传染)
(大三阳)
急性肝炎趋向恢复
(小三阳)
恢复期(传染性低)
-
-
-
-
-
+
-
+
-
既往感染或接种疫苗
未感染,无免疫力
Treatment and Prevention

Control the source of infection控制传染源
 Cut down the route of transmission切断传播途径

Passive immunization - Hepatitis B immune
globulin (HBIg)抗-HBs人血清球蛋白
 Active immunizations
–HBsAg vaccine

No specific treatment
hepatitis C virus,HCV
丙型肝炎病毒
predominant cause of non A non B hepatitis
Biological properties生物学性状
a member of the flavivirus 黄病毒属成员
 40~60nm,spherical球形
 an enveloped virion有包膜
 Genome: (+)ss RNA

Pathogenesis and Immunity
致病性与免疫性
 six genotypes基因型:Ⅰ、Ⅱ、Ⅲ、Ⅳ、Ⅴ、Ⅵ

transmitted by means similar to HBV
传播途径似HBV
– in infected blood (输血后肝炎)
 Intravenous drug abusers
 transfusion
 organ recipients
 hemophiliacs receiving factors Ⅷ or Ⅸ
– sexually
Pathogenesis
persistent, chronic hepatitis →cirrhosis肝硬化 ,
hepatocellular carcinoma肝癌

acute hepatitis
15%
 chronic persistent infection
70%
 severe rapid progression to cirrhosis
15%
Laboratory diagnosis

ELISA recognition of antibody
 genetic techniques to detect HCV RNA
Treatment防治原则

No vaccine尚无可用疫苗
 Recombinant IFN-αalone or with ribavirin
病毒唑
hepatitis D virus,HDV
丁型肝炎病毒

a defective virus that acquires an
HBsAg coat for transmissionHDV
是缺陷病毒,需以HBsAg构成其
衣壳来传播
 circular, single-stranded RNA
molecules and an internal core δ
antigen (HDAg) 单负链环状RNA
和δ 抗原(HDAg)
Pathogenesis

spread by the same routes as HBV: blood, semen, and
vaginal secretions
传播途径与HBV相同:血液,精液,阴道分泌物

increases the severity of HBV infections: Fulminant
hepatitis
加重HBV感染:爆发性肝炎
– Coinfection联合感染
– Superinfection重迭感染
Laboratory diagnosis

detecting the delta antigen ,RNA or antibodies病原

学检查为HDAg、抗HDV及HDV-RNA
Anti-HDV IgM
Persistant Anti-HDV IgG
chronic infection

Treatment and prevention


no known specific treatment
prevention of infection with HBV prevents HDV infection.
hepatitis E virus,HEV
戊型肝炎病毒

spherical, non-enveloped, and 27-34 nm
球形,无包膜,
 a positive-sense, single-strand RNA genome
单正链RNA

spread by the fecal-oral route为粪-口途径
传播
 symptoms and course of HEV disease are
similar to those of HAV disease
症状病程类似HAV
 Acute hepatitis ,mortality rate : 1% to 2%
 especially serious in pregnant women
(mortality rate of approximately 20%)孕妇感
染严重,病死率高达20%
Diagnosis
微生物学检查

HEV:EM or IEM电镜或免疫电镜
 Anti-HEV IgM
 HEV RNA
五种肝炎病毒比较
HAV
病毒结构 +ssRNA
传播途
径
病情
HBV
HCV
HDV
HEV
dsDNA
+ssRNA
-ssRNA
+ssRNA
粪-口
血液、性、垂直传播
轻
粪-口
慢性及
携带者
无
偶尔严重 亚临床,慢 需HBV 孕妇重
性多见
协助
有
无
实验室
检查
抗HAV
IgM
HBsAg-Ab
HBcAb
预防
疫苗
抗HCV
HCV-RNA
抗HDV
IgM
抗HEV
IgM
无
同HBV
预防为主
HBeAg-Ab
疫苗